Upgrade to SI Premium - Free Trial

Repros Therapeutics, Inc. (RPRX) Posts Q1 EPS Loss of $0.20

May 16, 2011 9:33 AM
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q1 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17).

Categories

Earnings